The expression of TAPBPL, SERPINB9, RCAN1, TMBIM4, JUNB, IL4R, and LY75 is significantly up-regulated in tumor samples with their high expression associated with a poor outcome; the expression of MGST3 is down-regulated in tumor samples with its low expression associated with poor prognosis (Figure 2, Figure S3 and Table S7). Here, TAPBPL is linked to neoplasm.